509 related articles for article (PubMed ID: 26055202)
1. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
2. The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Neural Transm (Vienna); 2015 Jan; 122(1):59-68. PubMed ID: 25448875
[TBL] [Abstract][Full Text] [Related]
3. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.
Liu Z; Zhu F; Wang G; Xiao Z; Tang J; Liu W; Wang H; Liu H; Wang X; Wu Y; Cao Z; Li W
Neurosci Lett; 2007 Mar; 414(2):155-8. PubMed ID: 17258395
[TBL] [Abstract][Full Text] [Related]
4. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
5. PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.
Schuhmacher A; Mössner R; Höfels S; Pfeiffer U; Guttenthaler V; Wagner M; Schwab SG; Maier W; Zobel A
Int J Neuropsychopharmacol; 2011 Mar; 14(2):237-45. PubMed ID: 20701824
[TBL] [Abstract][Full Text] [Related]
6. Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Psychopharmacol; 2015 May; 29(5):615-22. PubMed ID: 25294870
[TBL] [Abstract][Full Text] [Related]
7. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
8. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
Unschuld PG; Ising M; Roeske D; Erhardt A; Specht M; Kloiber S; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Jun; 35(7):1583-92. PubMed ID: 20237460
[TBL] [Abstract][Full Text] [Related]
9. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
Hikichi T; Akiyoshi J; Ichioka S; Tanaka Y; Tsuru J; Goto S; Matsushita H; Hanada H; Isogawa K; Nagayama H
Neuropsychobiology; 2007; 55(1):21-7. PubMed ID: 17556849
[TBL] [Abstract][Full Text] [Related]
10. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
Sarubin N; Nothdurfter C; Schüle C; Lieb M; Uhr M; Born C; Zimmermannc R; Bühner M; Konopka K; Rupprecht R; Baghai TC
J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
[TBL] [Abstract][Full Text] [Related]
11. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
[TBL] [Abstract][Full Text] [Related]
12. CRH, stress, and major depression: a psychobiological interplay.
Claes SJ
Vitam Horm; 2004; 69():117-50. PubMed ID: 15196881
[TBL] [Abstract][Full Text] [Related]
13. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
[TBL] [Abstract][Full Text] [Related]
14. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
Binder EB; Salyakina D; Lichtner P; Wochnik GM; Ising M; Pütz B; Papiol S; Seaman S; Lucae S; Kohli MA; Nickel T; Künzel HE; Fuchs B; Majer M; Pfennig A; Kern N; Brunner J; Modell S; Baghai T; Deiml T; Zill P; Bondy B; Rupprecht R; Messer T; Köhnlein O; Dabitz H; Brückl T; Müller N; Pfister H; Lieb R; Mueller JC; Lõhmussaar E; Strom TM; Bettecken T; Meitinger T; Uhr M; Rein T; Holsboer F; Muller-Myhsok B
Nat Genet; 2004 Dec; 36(12):1319-25. PubMed ID: 15565110
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the glucocorticoid receptor gene and major depression.
van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
[TBL] [Abstract][Full Text] [Related]
19. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression.
Duval F; Mokrani MC; Erb A; Gonzalez Lopera F; Alexa C; Proudnikova X; Butucaru I
Psychoneuroendocrinology; 2015 Sep; 59():71-80. PubMed ID: 26036452
[TBL] [Abstract][Full Text] [Related]
20. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
